TEVA GYOGYSZERGYAR ZARTKORUEN has a total of 60 patent applications. Its first patent ever was published in 1999. It filed its patents most often in Canada, China and Mexico. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are TEVA GYOGYSZERGYAR ZARTKOERUEE, BRITISH BIOTECH PHARM and ABBOTT GMBH & AMP CO KG.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 14 | |
#2 | China | 12 | |
#3 | Mexico | 7 | |
#4 | United States | 7 | |
#5 | Republic of Korea | 6 | |
#6 | WIPO (World Intellectual Property Organization) | 5 | |
#7 | Japan | 4 | |
#8 | Poland | 3 | |
#9 | EPO (European Patent Office) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Peptides | |
#6 | Fermentation | |
#7 | Unspecified technologies | |
#8 | Microorganisms | |
#9 | Sugars | |
#10 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Keri Vilmos | 23 |
#2 | Szabo Csaba | 15 |
#3 | Csorvasi Andrea | 10 |
#4 | Kovacsne-Mezei Adrienne | 8 |
#5 | Czovek Zoltan | 7 |
#6 | Tamas Tivadar | 7 |
#7 | Hajko Janos | 7 |
#8 | Aronhime Judith | 6 |
#9 | Molnar Sandor | 6 |
#10 | Korodi Ferenc | 5 |
Publication | Filing date | Title |
---|---|---|
CN102076707A | Caspofungin free of caspofungin impurity A | |
WO2009142761A1 | Caspofungin bo free of caspofungin co | |
WO2009014679A1 | Dolasetron trifluoroacetate, polymorphs of dolasetron trifluoroacetate and process for preparation thereof | |
US2007238739A1 | Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide (zaleplon) and crystalline forms of zaleplon accessible with the process | |
CA2619236A1 | Process for preparing simvastatin and intermediates thereof | |
CN101068820A | Non-hygroscopic and powdery amorphous pimecrolimus | |
CN1938005A | Process for preparation of amorphous form of a drug | |
MXPA06005659A | Process for preparation of mycophenolic acid and ester derivatives thereof. | |
CN1886125A | Method of purifying pravastatin | |
CN1856500A | Method of purifying macrolides | |
CN1768066A | Crystallization and purification of macrolides |